Cargando…
Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials
Patients with advanced chronic kidney disease exhibit an increase in cardiovascular mortality. Recent works have shown that low levels of magnesium are associated with increased cardiovascular and all-cause mortality in hemodialysis patients. Epidemiological studies suggest an influence of low level...
Autores principales: | Muñoz-Castañeda, Juan R., Pendón-Ruiz de Mier, María V., Rodríguez, Mariano, Rodríguez-Ortiz, María E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877525/ https://www.ncbi.nlm.nih.gov/pubmed/29495444 http://dx.doi.org/10.3390/ijms19030664 |
Ejemplares similares
-
Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
por: Muñoz-Castañeda, Juan Rafael, et al.
Publicado: (2020) -
The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities
por: Rodelo-Haad, Cristian, et al.
Publicado: (2020) -
FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019) -
Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics
por: Arenas, Maria Dolores, et al.
Publicado: (2020) -
Lack of Influence of Serum Magnesium Levels on Overall Mortality and Cardiovascular Outcomes in Patients with Advanced Chronic Kidney Disease
por: Ortega, Olimpia, et al.
Publicado: (2013)